Lisanti Capital Growth LLC Purchases New Holdings in Heartflow, Inc. $HTFL

Lisanti Capital Growth LLC acquired a new position in shares of Heartflow, Inc. (NASDAQ:HTFL) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 29,164 shares of the company’s stock, valued at approximately $982,000.

A number of other hedge funds also recently modified their holdings of the business. TFC Financial Management Inc. acquired a new stake in shares of Heartflow in the third quarter worth $40,000. Y Intercept Hong Kong Ltd purchased a new stake in Heartflow in the 3rd quarter worth about $234,000. TrueMark Investments LLC acquired a new stake in Heartflow during the 3rd quarter worth about $918,000. New York State Common Retirement Fund acquired a new position in shares of Heartflow in the 3rd quarter valued at about $4,015,000. Finally, Emerald Mutual Fund Advisers Trust purchased a new stake in shares of Heartflow in the third quarter worth approximately $4,418,000.

Analysts Set New Price Targets

Several research analysts have weighed in on HTFL shares. Canaccord Genuity Group upped their price objective on shares of Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Heartflow in a research note on Monday, December 29th. Wells Fargo & Company started coverage on Heartflow in a research report on Wednesday. They set an “overweight” rating and a $38.00 price objective for the company. Stifel Nicolaus raised their price target on Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Finally, JPMorgan Chase & Co. boosted their price target on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Heartflow currently has an average rating of “Moderate Buy” and a consensus target price of $38.50.

Insider Transactions at Heartflow

In related news, Director Jeffrey C. Lightcap bought 40,000 shares of the firm’s stock in a transaction on Tuesday, December 16th. The stock was purchased at an average price of $26.34 per share, with a total value of $1,053,600.00. Following the completion of the transaction, the director directly owned 40,000 shares of the company’s stock, valued at $1,053,600. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Heartflow Stock Down 3.1%

Shares of NASDAQ:HTFL opened at $29.87 on Friday. The firm has a market capitalization of $2.54 billion and a PE ratio of -16.50. The business has a 50-day moving average of $30.71. Heartflow, Inc. has a fifty-two week low of $25.38 and a fifty-two week high of $41.22.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.